Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Good manufacturing practice production of human stem cells for somatic cell and gene therapy.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Oxford University Press Country of Publication: England NLM ID: 9304532 Publication Model: Print Cited Medium: Print ISSN: 1066-5099 (Print) Linking ISSN: 10665099 NLM ISO Abbreviation: Stem Cells Subsets: MEDLINE
- Publication Information:
Publication: 2022- : Oxford : Oxford University Press
Original Publication: Dayton, OH : AlphaMed Press, c1993-
- Subject Terms:
- Abstract:
Peripheral blood stem cells (PBSC) are used for transplantation to reconstitute the hematopoietic system after high-dose chemotherapy. PBSC are harvested from peripheral blood upon successful mobilization by cytokines and/or chemotherapy. Further in vitro manipulation steps like enrichment of CD34+ PBSC or gene transfer can be performed. To ensure the quality and safety of the final cell preparations intended for transplantation, national and international guidelines and regulations have been issued. Herein the implementation of a quality assurance program including the principles of good manufacturing practice (GMP) and a quality control (QC) system is one major concern. GMP regulations apply to all phases of cell collection, processing and storage as well as documentation, training of personnel, and the laboratory facility. QC measures have to be taken to ensure consistent quality and safety with an emphasis on preventing any deficiencies.
- Number of References:
10
- Publication Date:
Date Created: 19970101 Date Completed: 19971218 Latest Revision: 20121115
- Publication Date:
20250114
- Accession Number:
10.1002/stem.5530150835
- Accession Number:
9368351
No Comments.